The US Meals and Drug Administration (FDA) in the present day accredited the JAK inhibitor momelotinib (Ojjaara) for myelofibrosis sufferers...
Approves
July 13, 2023 – The FDA’s approval as we speak of the primary contraception tablet for girls to be out...
July 6, 2023 – The FDA at the moment accredited a brand new remedy for early Alzheimer’s illness that seems...
Sotagliflozin, a novel agent that inhibits sodium-glucose cotransporter (SGLT) 1 in addition to SGLT2, obtained advertising and marketing approval from...
